View Post

His single-cell solution is revolutionizing cancer research

In In The News by Barbara Jacoby

By: Clayton Boldt, Ph.D. From: mdanderson.org Nicholas Navin wanted to better understand how tumors grow and evolve, so he found a way to analyze the DNA of individual cells Frustration often leads to innovation. Thomas Edison himself called discontent the “first necessity of progress.” For Nicholas Navin, Ph.D., it drove him to pioneer a technique that has revolutionized the way researchers are able …

View Post

Online tool can help Pennsylvania cancer patients decide where to have surgery

In In The News by Barbara Jacoby

By: Marie McCullough From: philly.com Hospitals that have lots of experience performing cancer surgeries have superior outcomes. Because of that well-documented link between cancer surgery volume and patient results, the Pennsylvania Health Care Cost Containment Council (PHC4) on Thursday posted updated online data showing hospital surgical volumes for 2018 for 11 types of cancer: bladder, brain, breast, colon, esophagus, liver, …

View Post

One Patient, One Stick: Nurses Launch Petition to Place Vascular Access Specialists in Every Hospital Across America

In In The News by Barbara Jacoby

Grassroots nurses group says legislation is needed to reduce patient pain and suffering from repeated needlesticks A coalition of nurses and the Association for Vascular Access have launched a drive to gather 100,000 signatures of the public and medical professionals to support a safety initiative by placing vascular access specialists in every hospital across America. The petition will be presented …

View Post

Barriers to Cancer Clinical Trial Enrollment

In Clinical Trials by Barbara Jacoby

By: Andrea S. Blevins Primeau, PhD, MBA From: cancertherapyadvisor.com Clinical trials are critical to developing new therapies and improving existing regimens for better efficacy and safety.1 Clinical trials can only be conducted if they enroll sufficient numbers of patients, and the more rapid the accrual, the sooner results can be collected and analyzed, and, ultimately, translated to the clinical setting. …

View Post

New cancer strategies promising, says researcher

In In The News by Barbara Jacoby

By: Martin Herrema From: medicalxpress.com Dr. Tim Fenton, an expert in cancer research at the University, says the announcement of new strategies to overcome the evolution of drug resistance in tumours could dramatically increase the effectiveness of cancer therapies. Dr. Fenton, of the University’s School of Biosciences, commented: “The Institute of Cancer Research (ICR) initiative announced today aims to develop …

View Post

A new approach to targeting cancer cells

In In The News by Barbara Jacoby

By: Iqbal Pittalwala From: ucr.edu A University of California, Riverside, research team has come up with a new approach to targeting cancer cells that circumvents a challenge faced by currently available cancer drugs. A cancer target is often a rogue protein that signals cancer cells to proliferate uncontrollably and invade organs. Modern cancer drugs have emerged that work by striking …

View Post

Cancer treatments: Patients need to know heart risks

In In The News by Barbara Jacoby

By: Maria Cohut From: medicalnewstoday.com Recent research on the health risks that people undergoing cancer treatment face warns that there is a lack of awareness about the risks that some of these therapies can pose to heart health. Investigators from Flinders University in Adelaide, Australia have found that many people who receive chemotherapy or radiotherapy for cancer risk their heart …

View Post

Breast cancer: Reducing this amino acid could make drugs more effective

In In The News by Barbara Jacoby

By: Catharine Paddock PhD From: medicalnewstoday.com Leucine, an amino acid that the body needs for making protein, appears to have a surprising role in the development of resistance to tamoxifen in breast cancer that tests positive for the estrogen receptor. Scientists from Harvard Medical School, in Boston, MA, recently made this “unexpected” discovery about estrogen receptor-positive (ER-positive) breast cancer in …